HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Célia S Bonnet Selected Research

Neoplasms (Cancer)

10/2021Doxorubicin-Sensitized Luminescence of NIR-Emitting Ytterbium Liposomes: Towards Direct Monitoring of Drug Release.
11/2020From Zn(II) to Cu(II) Detection by MRI Using Metal-Based Probes: Current Progress and Challenges.
11/2018A Porphyrin Dimer-GdDOTA Conjugate as a Theranostic Agent for One- and Two-Photon Photodynamic Therapy and MRI.
2/2016A Theranostic Agent Combining a Two-Photon-Absorbing Photosensitizer for Photodynamic Therapy and a Gadolinium(III) Complex for MRI Detection.
1/2016Four Gadolinium(III) Complexes Appended to a Porphyrin: A Water-Soluble Molecular Theranostic Agent with Remarkable Relaxivity Suited for MRI Tracking of the Photosensitizer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Célia S Bonnet Research Topics

Disease

5Neoplasms (Cancer)
10/2021 - 01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020
1Phototoxic Dermatitis (Phototoxicity)
02/2016

Drug/Important Bio-Agent (IBA)

1liposomal doxorubicin (Doxil)FDA Link
10/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021
1YtterbiumIBA
10/2021
1CopperIBA
11/2020
1CationsIBA
11/2020
1ZincIBA
11/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2018
1pyrithione zinc (ZPT)FDA Link
02/2016
1GadoliniumIBA
01/2016

Therapy/Procedure

1Precision Medicine
11/2018
1Photochemotherapy (Photodynamic Therapy)
11/2018